Mersana Therapeutics, Inc.

NASDAQ:MRSN

1.5 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Omzet 12.5982.2939.24510.7017.69810.6547.80214.6885.5734.2842.0360.0110.0110.0110.0110.0110.0110.7960.0110.0420.8440.20241.0351.1882.1514.1913.0643.2616.2673.7274.2911.9963.2626.2153.697
Kosten van de omzet 017.2450.4230.4470.4270.3240.3190.28250.63941.2310.20537.36835.27531.95527.41522.85716.54615.41312.21912.4313.70113.76615.14319.81715.1812.66312.25614.55511.41210.62710.1068.8457.5558.1717.436
Brutowinst 12.598-14.9528.82210.2547.27110.337.48314.406-45.066-36.9471.831-37.357-35.264-31.944-27.404-22.846-16.535-14.617-12.208-12.388-12.857-13.56425.892-18.629-13.029-8.472-9.192-11.294-5.145-6.9-5.8163.151-4.293-1.956-3.739
Brutowinstmarge 1-6.5210.9540.9580.9450.970.9590.981-8.086-8.6240.899-3,396.091-3,205.818-2,904-2,491.273-2,076.909-1,503.182-18.363-1,109.818-294.952-15.233-67.1490.631-15.681-6.057-2.021-3-3.463-0.821-1.851-1.3560.263-1.316-0.315-1.011
Onderzoek- en ontwikkelingskosten 14.80317.24518.68621.49530.53148.96847.27545.70950.63941.23135.80637.36835.27531.95527.41522.85716.54615.41312.21912.4313.70113.76615.14319.81615.1812.66312.25614.55511.41210.62710.1068.8457.5558.1717.436
Algemene en administratieve kosten 9.86410.50311.5610.13412.89418.18718.32814.80514.57314.80312.78210.67410.1248.8837.2085.9145.8815.1714.9364.2124.4364.1924.4434.1524.384.2313.5713.0562.9052.2042.2961.941.5981.8261.621
Verkoop- en marketingkosten 00-0.423-0.4470000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 9.86410.50311.1379.68712.89418.18718.32814.80514.57314.80312.78210.67410.1248.8837.2085.9145.8815.1714.9364.2124.4364.1924.4434.1524.384.2313.5713.0562.9052.2042.2961.941.5981.8261.621
Overige kosten -12.06900-1.6958.2142.19400.902-0.17200-0.9520-0.08600-0.073000000.4520.349000.3600.318000000
Bedrijfskosten 12.59827.74829.82331.18251.63967.15565.60360.51465.21256.03448.58848.04245.39940.83834.62328.77122.42720.58417.15516.64218.13717.95819.58623.96819.5616.89415.82717.61114.31712.83112.40210.7859.1539.9979.057
Bedrijfsresultaat -12.069-25.455-21.001-20.928-41.656-54.307-55.18-46.108-59.639-51.75-46.534-48.002-45.388-40.827-34.612-28.76-22.416-19.788-17.144-16.599-17.293-17.75621.449-22.781-17.409-12.703-12.763-14.35-8.05-9.104-8.1121.211-5.891-3.782-5.36
Bedrijfsresultaat ratio -0.958-11.101-2.272-1.956-5.411-5.097-7.073-3.139-10.701-12.08-22.856-4,363.818-4,126.182-3,711.545-3,146.545-2,614.545-2,037.818-24.859-1,558.545-395.214-20.489-87.9010.523-19.176-8.093-3.031-4.165-4.4-1.285-2.443-1.8910.101-1.806-0.609-1.45
Totaal overige inkomsten en kosten netto 0.9861.1871.6951.384-5.9292.1941.6380.902-0.172-0.469-0.706-0.952-0.083-0.086-0.081-0.08-0.0730.0020.2180.3530.5010.6850.4520.3490.340.3490.360.3830.3180.1580.0510.0480.0540.0160.004
Inkomen voor belasting -11.083-24.268-19.306-19.544-41.656-54.307-56.163-44.924-59.811-52.219-47.258-48.983-45.471-40.913-34.693-28.842-22.489-19.786-16.926-16.246-16.792-17.07121.901-22.431-17.069-12.354-12.403-13.967-7.732-8.946-8.0611.259-5.837-3.766-5.356
Inkomen voor belasting ratio -0.88-10.584-2.088-1.826-5.411-5.097-7.199-3.059-10.732-12.189-23.211-4,453-4,133.727-3,719.364-3,153.909-2,622-2,044.455-24.857-1,538.727-386.81-19.896-84.510.534-18.881-7.935-2.948-4.048-4.283-1.234-2.4-1.8790.105-1.789-0.606-1.449
Belastingkosten 0.41800.385.697-6.356-0.3240.9830.964-0.2130.2910.7240.9810.015-0.2060.0120.01-0.2560.0890.3060.1580.6080.725-0.337-0.3500-0.2580-0.235000000
Nettowinst -11.501-24.268-19.306-19.544-41.656-54.307-57.146-45.888-59.811-52.219-47.982-48.983-45.471-40.913-34.693-28.842-22.489-19.786-16.926-16.246-16.792-17.07121.901-22.431-17.069-12.354-12.403-13.967-7.732-8.946-8.0611.259-5.837-3.766-5.356
Nettowinstmarge -0.913-10.584-2.088-1.826-5.411-5.097-7.325-3.124-10.732-12.189-23.567-4,453-4,133.727-3,719.364-3,153.909-2,622-2,044.455-24.857-1,538.727-386.81-19.896-84.510.534-18.881-7.935-2.948-4.048-4.283-1.234-2.4-1.8790.105-1.789-0.606-1.449
WPA (Winst Per Aandeel) -0.094-0.2-0.16-0.16-0.35-0.47-0.53-0.45-0.61-0.55-0.6-0.68-0.63-0.59-0.5-0.42-0.33-0.33-0.35-0.34-0.35-0.360.72-0.97-0.74-0.54-0.54-0.61-0.35-6.33-0.360.072-0.33-0.22-0.31
Verwaterde WPA -0.094-0.2-0.16-0.16-0.35-0.47-0.53-0.45-0.61-0.55-0.6-0.68-0.63-0.59-0.5-0.42-0.33-0.33-0.35-0.34-0.35-0.360.7-0.97-0.74-0.54-0.54-0.61-0.35-6.33-0.360.072-0.33-0.22-0.31
EBITDA -11.667-22.882-17.881-18.049-40.212-52.958-54.861-43.678-58.718-51.232-46.329-47.791-45.161-40.612-34.374-28.492-22.141-19.453-16.59-15.877-16.375-16.71521.786-22.431-16.727-12.047-12.505-14.095-7.815-8.875-7.9031.417-5.707-3.632-5.245
EBITDA ratio -0.926-9.979-2.226-1.914-5.411-5.303-7.032-3.12-10.701-11.959-22.755-4,366.455-4,105.545-3,711.545-3,124.909-2,590-2,037.818-24.438-1,508.182-384.738-19.402-82.7480.523-19.175-7.934-2.958-4.165-4.322-1.285-2.381-1.8420.118-1.75-0.584-1.419